JPS5735512A
(en)
|
1980-06-27 |
1982-02-26 |
Nippon Oil & Fats Co Ltd |
Preventive and remedy for thrombosis
|
US4377526A
(en)
|
1981-05-15 |
1983-03-22 |
Nippon Suisan Kaisha, Ltd. |
Method of purifying eicosapentaenoic acid and its esters
|
BR8803255A
(pt)
|
1981-11-10 |
1990-02-06 |
Century Lab Inc |
Processo de extracao e purificacao de acidos graxos poli-insaturados de fontes naturais
|
JPS59157018A
(ja)
|
1983-02-27 |
1984-09-06 |
Furointo Sangyo Kk |
新規なる被覆含油カプセル剤形
|
JPS59225115A
(ja)
|
1983-06-06 |
1984-12-18 |
Ota Seiyaku Kk |
青魚類から得た長鎖高度不飽和脂肪酸を含有する微細カプセル
|
JPS61126016A
(ja)
|
1984-11-22 |
1986-06-13 |
Toagosei Chem Ind Co Ltd |
不飽和脂肪酸を内相物としたマイクロカプセル
|
EP0347509A1
(en)
|
1988-06-21 |
1989-12-27 |
Century Laboratories Inc. |
A process of extraction and purification of polyunsaturated fatty acids from natural sources
|
CH669208A5
(fr)
|
1986-12-17 |
1989-02-28 |
Nestle Sa |
Procede de fractionnement en continu d'un melange d'acides gras.
|
US5243046A
(en)
|
1986-12-17 |
1993-09-07 |
Nestec S.A. |
Process for the continuous fractionation of a mixture of fatty acids
|
ES2040847T3
(es)
|
1987-04-27 |
1996-07-16 |
Efamol Holdings |
Un procedimiento para preparar una composicion farmaceutica que contiene una sal de litio.
|
IT1205043B
(it)
|
1987-05-28 |
1989-03-10 |
Innova Di Ridolfi Flora & C S |
Procedimento per l'estrazione di esteri di acidi grassi poliinsaturi da olii di pesce e composizioni farmaceutiche e dietetiche contenenti detti esteri
|
US4843095A
(en)
|
1987-08-07 |
1989-06-27 |
Century Laboratories, Inc. |
Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis
|
ZA885473B
(en)
|
1987-08-07 |
1989-03-29 |
Century Lab Inc |
Free fatty acids for treatment of diabetes mellitus
|
GB8819110D0
(en)
|
1988-08-11 |
1988-09-14 |
Norsk Hydro As |
Antihypertensive drug & method for production
|
GB2223943A
(en)
|
1988-10-21 |
1990-04-25 |
Tillotts Pharma Ag |
Oral disage forms of omega-3 polyunsaturated acids
|
NL9201438A
(nl)
|
1992-08-11 |
1994-03-01 |
Prospa Bv |
Nieuwe farmaceutische samenstellingen die esters van omega-3 polyonverzadigde zuren omvatten en de toepassing ervan bij de plaatselijke behandeling van ziekelijke aandoeningen.
|
EP0679057B1
(en)
|
1993-01-15 |
1999-08-18 |
Abbott Laboratories |
Structured lipids
|
AU676910B2
(en)
|
1993-04-29 |
1997-03-27 |
Norsk Hydro A.S |
Processes for chromatographic fractionation of fatty acids and their derivatives
|
JPH0753356A
(ja)
|
1993-08-16 |
1995-02-28 |
Morishita Jintan Kk |
酸化され易い油性物質を内容物とするシームレスカプセルおよびその製造方法
|
US5767156A
(en)
|
1993-10-06 |
1998-06-16 |
Peptide Technology Limited |
Polyunsaturated fatty acids and uses thereof
|
IT1264987B1
(it)
|
1993-12-14 |
1996-10-17 |
Prospa Bv |
Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
|
US5494684A
(en)
|
1994-02-23 |
1996-02-27 |
Bar-Ilan University |
Plant protection from infection by Phytophthora infestans using fish oil
|
GB9404483D0
(en)
|
1994-03-08 |
1994-04-20 |
Norsk Hydro As |
Refining marine oil compositions
|
RU2127115C1
(ru)
|
1994-03-28 |
1999-03-10 |
Владимир Константинович Гаврисюк |
Смесь омега-3 полиненасыщенных жирных кислот
|
ES2131129T3
(es)
|
1994-05-09 |
1999-07-16 |
Nestle Sa |
Procedimiento para la preparacion de un concentrado de esteres de acidos grasos poliinsaturados.
|
IT1274734B
(it)
|
1994-08-25 |
1997-07-24 |
Prospa Bv |
Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
|
JPH08100191A
(ja)
*
|
1994-09-30 |
1996-04-16 |
Nisshin Flour Milling Co Ltd |
高度不飽和脂肪酸またはそのエステルの精製方法
|
NL9401743A
(nl)
|
1994-10-20 |
1996-06-03 |
Prospa Bv |
Zouten van aminoalcoholen en farmaceutische formuleringen die deze bevatten.
|
GB2300807B
(en)
|
1995-05-15 |
1999-08-18 |
Tillotts Pharma Ag |
Oral dosage forms of omega-3 polynunsaturated acids for the treatment of inflammatory bowel disease
|
GB9509764D0
(en)
|
1995-05-15 |
1995-07-05 |
Tillotts Pharma Ag |
Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
|
WO1997039759A2
(en)
|
1996-04-24 |
1997-10-30 |
Brigham And Women's Hospital |
Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder
|
US6077828A
(en)
|
1996-04-25 |
2000-06-20 |
Abbott Laboratories |
Method for the prevention and treatment of cachexia and anorexia
|
JPH1095744A
(ja)
*
|
1996-09-20 |
1998-04-14 |
Nof Corp |
高度不飽和脂肪酸又はそのアルキルエステルの製造方法
|
DE69622722T2
(de)
|
1996-11-20 |
2003-02-27 |
Nutricia Nv |
Fette enthaltende Ernährungszusammensetzung zur Behandlung des Stoffwechselsyndroms
|
GB9701705D0
(en)
|
1997-01-28 |
1997-03-19 |
Norsk Hydro As |
Purifying polyunsatured fatty acid glycerides
|
AU6184298A
(en)
|
1997-02-25 |
1998-09-09 |
Genzyme Transgenics Corporation |
Transgenically produced non-secreted proteins
|
US6852870B2
(en)
|
1999-03-22 |
2005-02-08 |
Andrew Stoll |
Omega-3 fatty acids in the treatment of depression
|
ATE497384T1
(de)
|
1997-12-10 |
2011-02-15 |
Cyclosporine Therapeutics Ltd |
Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
|
NO312973B1
(no)
|
1999-02-17 |
2002-07-22 |
Norsk Hydro As |
Lipase-katalysert forestring av marine oljer
|
US7112609B2
(en)
|
1999-06-01 |
2006-09-26 |
Drugtech Corporation |
Nutritional supplements
|
JP2001054396A
(ja)
|
1999-06-08 |
2001-02-27 |
Nippon Suisan Kaisha Ltd |
リパーゼによる高度不飽和脂肪酸含有油脂の製造方法
|
WO2001006983A2
(en)
|
1999-07-22 |
2001-02-01 |
Incell Corporation, Llc |
Fatty acids to minimize cancer therapy side effects
|
NO310113B1
(no)
|
1999-08-11 |
2001-05-21 |
Norsk Hydro As |
Fremgangsmåte for utvinning av flerumettede fettsyrer fra ureakomplekser
|
WO2001015552A1
(en)
|
1999-08-30 |
2001-03-08 |
Ocean Nutrition Canada Ltd. |
A nutritional supplement for lowering serum triglyceride and cholesterol levels
|
WO2001015702A1
(fr)
|
1999-08-31 |
2001-03-08 |
Chugai Seiyaku Kabushiki Kaisha |
Capsules molles
|
EP1106072B1
(en)
|
1999-12-10 |
2005-11-30 |
Loders Croklaan B.V. |
Palmitoleic acid and its use in foods
|
AU2634101A
(en)
|
2000-01-06 |
2001-07-16 |
Martek Biosciences Corporation |
Therapeutic preparations of highly unsaturated fatty acids
|
EP1157692B1
(en)
|
2000-05-22 |
2005-10-05 |
Pro Aparts - Investimentos E Consultoria Lda |
Composition of fatty acids containing at least 80% by weight of EPA and DHA or their derivatives and its pharmaceutical use
|
GB0016045D0
(en)
|
2000-06-29 |
2000-08-23 |
Laxdale Limited |
Therapeutic combinations of fatty acids
|
GB0016452D0
(en)
|
2000-07-04 |
2000-08-23 |
Kilgowan Limited |
Vitamin K and essential fatty acids
|
EP1178103A1
(en)
|
2000-08-02 |
2002-02-06 |
Dsm N.V. |
Purifying crude pufa oils
|
KR20010008387A
(ko)
|
2000-11-30 |
2001-02-05 |
이성권 |
결정화방법을 이용한 고순도 불포화지방산의 분리 정제 방법
|
DK1406641T3
(da)
|
2001-06-18 |
2009-05-04 |
Neptune Technologies & Bioress |
Krillekstrakter til forebyggelse og/eller behandling af cardiovaskulære sygdomme
|
CN1197564C
(zh)
*
|
2001-09-30 |
2005-04-20 |
中国药品生物制品检定所 |
海狗油在制备治疗脂代谢紊乱药物中的应用
|
ITMI20012384A1
(it)
|
2001-11-12 |
2003-05-12 |
Quatex Nv |
Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
|
GB2385852A
(en)
|
2002-02-27 |
2003-09-03 |
Rothamsted Ex Station |
Delta 6-desaturases from Primulaceae
|
AU2003218319A1
(en)
|
2002-03-22 |
2003-10-13 |
Doc's Guide, Inc. |
Multivitamin and mineral nutritional supplement
|
DE10214005A1
(de)
|
2002-03-27 |
2003-10-09 |
Volker Bartz |
Blutfettsenker zur oralen Einnahme, bestehend aus einem Gemisch aus den Omega-3-Fettsäuren EPA (Eicosapentaensäure) und DHA (Docosapentaensäure) und Pektin und/oder Guar als wirksame Substanzen, sowie gegebenenfalls zusätzlichen Stoffen wie antioxidative Vitamine, Aminosäuren und Spurenelemente
|
ITMI20020731A1
(it)
|
2002-04-08 |
2003-10-08 |
Ibsa Inst Biochimique Sa |
Composizioni farmaceutiche per acido acetilsalicilico e oli omega-3
|
NZ518504A
(en)
|
2002-04-22 |
2005-05-27 |
Ind Res Ltd |
Use of near-critical fluids in the separation of saturated and mono-unsaturated fatty acids from urea-containing solutions
|
EP2295529B2
(en)
|
2002-07-11 |
2022-05-18 |
Basf As |
Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use
|
SE0202188D0
(sv)
|
2002-07-11 |
2002-07-11 |
Pronova Biocare As |
A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
|
NO319194B1
(no)
|
2002-11-14 |
2005-06-27 |
Pronova Biocare As |
Lipase-katalysert forestringsfremgangsmate av marine oljer
|
US8017651B2
(en)
|
2002-11-22 |
2011-09-13 |
Bionexus, Ltd. |
Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia
|
WO2004056370A1
(en)
|
2002-12-20 |
2004-07-08 |
Pronova Biocare As |
Use of a fatty acid composition for treatment of male infertility
|
EP1622467A1
(en)
|
2003-05-05 |
2006-02-08 |
Denofa AS |
Fish oils with an altered fatty acid profile, method of producing same and their use
|
US6846942B2
(en)
|
2003-05-20 |
2005-01-25 |
David Rubin |
Method for preparing pure EPA and pure DHA
|
WO2005005585A1
(ja)
|
2003-07-09 |
2005-01-20 |
J-Oil Mills, Inc. |
長鎖高度不飽和脂肪酸を含む抗酸化油脂組成物
|
US7759507B2
(en)
|
2003-09-05 |
2010-07-20 |
Abbott Laboratories |
Lipid system and methods of use
|
ITMI20032247A1
(it)
|
2003-11-19 |
2005-05-20 |
Tiberio Bruzzese |
Interazione di derivati polari di composti insaturi con substrati inorganici
|
SE0303513D0
(sv)
|
2003-12-19 |
2003-12-19 |
Pronova Biocare As |
Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
|
GB0403247D0
(en)
*
|
2004-02-13 |
2004-03-17 |
Tillotts Pharma Ag |
A pharmaceutical composition
|
GB0413730D0
(en)
|
2004-06-18 |
2004-07-21 |
Tillotts Pharma Ag |
A pharmaceutical composition and its use
|
GB0413729D0
(en)
|
2004-06-18 |
2004-07-21 |
Tillotts Pharma Ag |
A pharmaceutical composition and its use
|
US20070265341A1
(en)
|
2004-07-01 |
2007-11-15 |
The Schepens Eye Research Institute Inc. |
Compositions and methods for treating eye disorders and conditions
|
US20080193549A1
(en)
|
2004-07-05 |
2008-08-14 |
Otago Innovation Limited |
Hoki Fish Liver Oil, Fractions Thereof And Therapeutic Uses
|
MX2007000813A
(es)
|
2004-07-19 |
2007-06-05 |
Thia Medica As |
Composicion que comprende aceites de pescado y/o de planta y compuestos que comprenden entidades de acido graso no oxidable.
|
RU2394598C2
(ru)
|
2004-07-19 |
2010-07-20 |
Тиа Медика Ас |
Композиция, содержащая белковый материал и соединения, содержащие неокисляющиеся структурные элементы жирных кислот
|
WO2007130714A1
(en)
|
2006-02-01 |
2007-11-15 |
Transform Pharmaceuticals, Inc. |
Novel statin pharmaceutical compositions and related methods of treatment
|
JP2008509154A
(ja)
*
|
2004-08-06 |
2008-03-27 |
トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド |
新規なスタチン薬剤組成物および関連治療方法
|
WO2007130713A1
(en)
|
2006-02-01 |
2007-11-15 |
Transform Pharmaceuticals, Inc. |
Novel fenofibrate formulations and related methods of treatment
|
NZ552390A
(en)
|
2004-08-06 |
2010-01-29 |
Transform Pharmaceuticals Inc |
Novel fenofibrate formulations and related methods of treatment
|
US7829708B2
(en)
|
2004-09-08 |
2010-11-09 |
Chelsea Therapeutics, Inc. |
Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation
|
WO2006036982A2
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Drug delivery coating for use with a stent
|
US20070191467A1
(en)
*
|
2004-12-06 |
2007-08-16 |
Reliant Pharmaceutical, Inc. |
Statin and omega-3 fatty acids for lipid therapy
|
DE102004062141A1
(de)
|
2004-12-23 |
2006-07-06 |
Nutrinova Nutrition Specialties & Food Ingredients Gmbh |
Verfahren zur Herstellung eines Rohöls aus Gemischen von Mikroorganismen und Pflanzen, das so hergestellte Öl sowie die spezifischen Verwendungen des so hergestellten und gegebenenfalls zusätzlich raffinierten Öls
|
JP5503846B2
(ja)
|
2005-01-24 |
2014-05-28 |
プロノヴァ・バイオファーマ・ノルゲ・アーエス |
アミロイドーシス関連疾患の治療のための医療品又は食料品の製造における、dhaを含有する脂肪酸組成物の使用
|
EP1858352B1
(en)
|
2005-02-18 |
2013-06-05 |
Delante Health AS |
A composition comprising a powder containing microencapsulated polyunsaturated long-chain esterified fatty acids distributed in an effervescent base
|
EP1861087A4
(en)
|
2005-03-08 |
2010-02-10 |
Reliant Pharmaceuticals Inc |
TREATMENT WITH STATINE AND OMEGA-3-FATTY ACID AS A COMBINATION PRODUCT THEREOF
|
DE102005013779A1
(de)
|
2005-03-22 |
2006-09-28 |
Basf Plant Science Gmbh |
Verfahren zur Herstellung von mehrfach ungesättigten C20- und C22-Fettsäuren mit mindestens vier Doppelbindungen in transgenen Pflanzen
|
WO2006102896A2
(en)
|
2005-03-29 |
2006-10-05 |
Aalborg Universitet |
A process to concentrate ω3-pufa from fish oil by selective hydrolysis using cutinase immobilized on zeolite nay
|
KR100539357B1
(ko)
|
2005-04-11 |
2005-12-28 |
동부한농화학 주식회사 |
불포화 지방산의 제조방법
|
US20090203778A1
(en)
|
2005-05-04 |
2009-08-13 |
Morten Bryhn |
Fatty acid analogues, i.e. including dha derivatives for uses as a medicament
|
US7485323B2
(en)
|
2005-05-31 |
2009-02-03 |
Gelita Ag |
Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
|
EA200800225A1
(ru)
|
2005-07-01 |
2008-06-30 |
Мартек Байосайенсиз Корпорейшн |
Содержащий полиненасыщенные жирные кислоты маслопродукт и его применения и получение
|
US20070020340A1
(en)
|
2005-07-25 |
2007-01-25 |
David Rubin |
Fish oil products for reducing cholesterol, low density lipoprotein, and hypertension
|
EP1922065A4
(en)
|
2005-08-04 |
2009-11-11 |
Transform Pharmaceuticals Inc |
NEW FORMULATIONS WITH FENOFIBRATE AND A STATIN AND RELEVANT TREATMENT PROCESS
|
ITMI20051560A1
(it)
|
2005-08-10 |
2007-02-11 |
Tiberio Bruzzese |
Composizione di acidi grassi n-3 con elevata concentrazione di epa e-o dha e contenente acidi grassi n-6
|
US20070134493A1
(en)
|
2005-12-08 |
2007-06-14 |
Kanji Meghpara |
Compositions and capsules with stable hydrophilic layers
|
EP2364701A1
(en)
|
2005-12-20 |
2011-09-14 |
Cenestra, Llc |
Omega-3 fatty acid formulations
|
FR2896172B1
(fr)
|
2006-01-17 |
2008-10-10 |
Polaris Soc Par Actions Simpli |
Nouveau procede de stabilisation des acides gras polyinsatures et les compositions ainsi obtenus.
|
DE102006008030A1
(de)
|
2006-02-21 |
2007-08-23 |
Basf Plant Science Gmbh |
Verfahren zur Herstellung von mehrfach ungesättigten Fettsäuren
|
AR059376A1
(es)
|
2006-02-21 |
2008-03-26 |
Basf Plant Science Gmbh |
Procedimiento para la produccion de acidos grasos poliinsaturados
|
WO2007128801A1
(en)
|
2006-05-08 |
2007-11-15 |
Novartis Ag |
Combination of organic compounds
|
US8003813B2
(en)
|
2006-06-27 |
2011-08-23 |
Pos Pilot Plant Corporation |
Process for separating saturated and unsaturated fatty acids
|
KR100684641B1
(ko)
|
2006-07-25 |
2007-02-22 |
주식회사 일신웰스 |
유지 조성물, 이를 함유하는 식품 및 건강보조식품
|
WO2008012329A2
(en)
|
2006-07-28 |
2008-01-31 |
V. Mane Fils |
Seamless capsules containing high amounts of polyunsaturated fatty acids and a flavouring component
|
KR100758664B1
(ko)
|
2006-08-16 |
2007-09-13 |
(주)케비젠 |
불포화지방산 함유 마이크로캡슐의 제조방법, 이 방법에의해 제조된 마이크로캡슐 및 이를 포함하는 제품
|
CN101194913A
(zh)
*
|
2006-12-05 |
2008-06-11 |
张金生 |
治疗血脂偏高的天然海豹油浓缩生物制剂及其制备工艺
|
ES2604081T3
(es)
|
2007-01-10 |
2017-03-02 |
Dsm Nutritional Products Ag |
Microcápsulas que incluyen proteína de guisante
|
JP2010515773A
(ja)
|
2007-01-16 |
2010-05-13 |
リライアント・ファーマシューティカルズ・インコーポレイテッド |
非ステロイド系抗炎症薬およびオメガ−3脂肪酸を用いる治療ならびにその組合せ生成物
|
CN101663031A
(zh)
|
2007-02-20 |
2010-03-03 |
马泰克生物科学公司 |
来自长链多不饱和脂肪酸的氧脂素及其制备方法和使用方法
|
AU2008229604B2
(en)
|
2007-03-20 |
2013-05-30 |
Scf Pharma Inc. |
Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
|
CA2685272A1
(en)
|
2007-04-26 |
2008-11-06 |
Patrick Adlercreutz |
A polyunsaturated fatty acid (pufa) enriched marine oil comprising eicosapentaenoic acid (epa) and docosahexaenoic acid (dha), and a process of production thereof
|
WO2009009040A2
(en)
|
2007-07-06 |
2009-01-15 |
Baum Seth J |
Fatty acid compositions and methods of use
|
CL2008002020A1
(es)
|
2007-07-12 |
2008-11-14 |
Ocean Nutrition Canada Ltd |
Metodo de modificacion de un aceite, que comprende hidrolizar gliceridos con una solucion de lipasa thermomyces lanuginosus, separar la fraccion de acido graso saturado de la fraccion de glicerido hidrolizado y esterificar los gliceridos hidrolizados en la presencia de candida antarctica lipasa b; y composicion de aceite.
|
CA2694054C
(en)
|
2007-07-25 |
2015-11-17 |
Epax As |
Omega-3 fatty acid fortified composition
|
JP5204776B2
(ja)
|
2007-07-30 |
2013-06-05 |
日本水産株式会社 |
Epa濃縮油およびdha濃縮油の製造方法
|
WO2009020406A1
(en)
|
2007-08-07 |
2009-02-12 |
Granate Seed Limited |
Methods of making lipid substances, lipid substances made thereby and uses thereof
|
WO2009028457A1
(ja)
|
2007-08-29 |
2009-03-05 |
Shinshu University |
非アルコール性脂肪肝炎治療薬
|
DE102007055344A1
(de)
|
2007-11-19 |
2009-05-20 |
K. D. Pharma Bexbach Gmbh |
Neue Verwendung von Omega-3-Fettsäure(n)
|
CN101969932A
(zh)
|
2008-01-10 |
2011-02-09 |
武田药品工业株式会社 |
胶囊制剂
|
US20090182049A1
(en)
|
2008-01-16 |
2009-07-16 |
Joar Arild Opheim |
Pharmaceutical Composition and Method for Treating Hypertriglyceridemia and Hypercholesterolemia in Humans
|
KR20110021886A
(ko)
|
2008-05-15 |
2011-03-04 |
프로노바 바이오파마 노르지 에이에스 |
크릴 오일 처리 방법
|
EP3187182B1
(en)
|
2008-09-02 |
2021-03-03 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
|
US20100062057A1
(en)
|
2008-09-10 |
2010-03-11 |
Pronova BioPharma Norge AS. |
Formulation
|
PL2337857T3
(pl)
|
2008-10-02 |
2017-09-29 |
Gonzalez Ramon |
Ekstrakt z mikroalg zawierający 3-wielonienasycone kwasy tłuszczowe i sposób ekstrakcji oleju z mikroorganizmów
|
WO2010049954A1
(en)
|
2008-10-31 |
2010-05-06 |
Lipid Pharmaceuticals Ehf. |
Fatty acids for use as a medicament
|
MX2011008448A
(es)
|
2009-02-10 |
2012-02-28 |
Amarin Pharma Inc |
Uso de ester etilico del acido eisosapentaenoico para tratar hipertrigliceridemia.
|
CN101822651A
(zh)
*
|
2009-03-05 |
2010-09-08 |
Dpa工业公司 |
可咀嚼胶囊及其制备方法
|
CN110538148A
(zh)
|
2009-03-09 |
2019-12-06 |
巴斯夫股份公司 |
含有脂肪酸油混合物和表面活性剂的组合物及其方法和用途
|
ES2574136T5
(es)
|
2009-04-17 |
2019-08-30 |
Natac Pharma S L |
Composiciones ricas en ácidos grasos omega 3 con un bajo contenido en ácido fitánico
|
NO2424356T3
(es)
|
2009-04-29 |
2018-01-20 |
|
|
EP3563842A1
(en)
|
2009-04-29 |
2019-11-06 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
|
PL2419114T5
(pl)
|
2009-05-01 |
2019-09-30 |
Uas Laboratories Llc |
Kompozycje bakteryjne do profilaktyki i leczenia choroby degeneracyjnej
|
ES2661217T3
(es)
*
|
2009-06-15 |
2018-03-28 |
Amarin Pharmaceuticals Ireland Limited |
Composiciones y métodos para reducir los triglicéridos sin aumentar los niveles de LDL-C en un sujeto en terapia simultánea con estatinas
|
IN2012DN02661A
(es)
|
2009-09-01 |
2015-09-11 |
Catabasis Pharmaceuticals Inc |
|
WO2011038122A1
(en)
|
2009-09-23 |
2011-03-31 |
Amarin Corporation Plc |
Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
|
ES2895477T3
(es)
|
2009-10-23 |
2022-02-21 |
Basf As |
Cápsulas y comprimidos revestidos de una mezcla de aceites de ácidos grasos
|
RU2009145010A
(ru)
|
2009-12-04 |
2011-06-20 |
Общество с ограниченной ответственностью (ООО) "Аббифарм" (RU) |
Композиция омега-3 и омега-6 полиненасыщенных жирных кислот
|
WO2011095284A1
(de)
|
2010-02-02 |
2011-08-11 |
Cognis Ip Management Gmbh |
Anreicherung von mehrfach ungesättigten fettsäuren
|
GB201006204D0
(en)
|
2010-04-14 |
2010-06-02 |
Ayanda As |
Composition
|
WO2011133610A1
(en)
|
2010-04-22 |
2011-10-27 |
E. I. Du Pont De Nemours And Company |
Method for obtaining polyunsaturated fatty acid-containing compositions from microbial biomass
|
US9476008B2
(en)
|
2010-06-25 |
2016-10-25 |
Epax As |
Process for separating polyunsaturated fatty acids from long chain unsaturated or less saturated fatty acids
|
US20140004186A1
(en)
|
2010-09-08 |
2014-01-02 |
Pronova Biopharma Norge As |
Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin
|
US9145533B2
(en)
|
2010-09-24 |
2015-09-29 |
Pronova Blopharm Norge AS |
Process for concentrating omega-3 fatty acids
|
WO2012083034A1
(en)
|
2010-12-15 |
2012-06-21 |
Louis Sanfilippo |
Modulation of neurotrophic factors by omega-3 fatty acid formulations
|
WO2012087153A1
(en)
|
2010-12-23 |
2012-06-28 |
Marine Bioproducts As |
Enrichment of marine oils with omega-3 polyunsaturated fatty acids by lipase-catalysed hydrolysis
|
EP2476425B1
(en)
|
2011-01-14 |
2014-03-19 |
Visiotact Pharma |
Composition comprising OPC and Omega-3 for preventing and/or inhibiting the development of diabetic retinopathy
|
EP2675445A1
(en)
|
2011-02-16 |
2013-12-25 |
Pivotal Therapeutics, Inc. |
Statin and omega 3 fatty acids (epa, dha and dpa) for use in cardiovascular diseases
|
WO2012112511A1
(en)
*
|
2011-02-16 |
2012-08-23 |
Pivotal Therapeutics, Inc. |
Cholesterol absorption inhibitor (azetidinone) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events
|
CA2827577A1
(en)
|
2011-02-16 |
2012-08-23 |
Pivotal Therapeutics, Inc. |
A formulations comprising omega 3 fatty acids and an anti obesity agent for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics
|
CA2827561A1
(en)
*
|
2011-02-16 |
2012-08-23 |
Pivotal Therapeutics, Inc. |
Omega 3 fatty acid diagniostic assay for the dietary management of patients with cardiovascular disease (cvd)
|
JP2014505731A
(ja)
*
|
2011-02-16 |
2014-03-06 |
ピヴォタル セラピューティクス インコーポレイテッド |
心血管疾患のリスク因子を治療するための、EPA、DHAおよびDPAを含むω3製剤
|
WO2012112902A1
(en)
|
2011-02-18 |
2012-08-23 |
Martek Biosciences Corporation |
Methods of preparing free polyunsaturated fatty acids
|
WO2012156986A1
(en)
|
2011-04-28 |
2012-11-22 |
Duragkar Nandakishore Jeevanrao |
Eicosapentaenoic acid (epa) as polyunsaturated free fatty acid in its directly compressible powder form and process of isolation thereof
|
CN102311868B
(zh)
|
2011-04-29 |
2017-05-24 |
塞拉斯有限责任公司 |
一种无溶剂提取富含磷脂和中性油脂的磷虾油的方法
|
US8697676B2
(en)
|
2011-06-15 |
2014-04-15 |
Ronald E Rosedale |
Omega-3 fatty acid nutriceutical composition and optimization method
|
EP2755646A4
(en)
|
2011-09-15 |
2015-06-10 |
Omthera Pharmaceuticals Inc |
METHOD AND COMPOSITIONS FOR TREATING, REVERSING, INHIBITING OR PREVENTING RESISTANCE TO THROMBIA THERAPY
|
WO2013059669A1
(en)
|
2011-10-21 |
2013-04-25 |
Omthera Pharmaceuticals, Inc. |
Methods and compositions for treating or preventing attention deficit hyperactivity disorder
|
US9861605B2
(en)
|
2011-10-24 |
2018-01-09 |
Stable Solutions Llc |
Enriched injectable emulsion containing selected fatty acid triglycerides
|
UA114615C2
(uk)
|
2012-01-06 |
2017-07-10 |
Омтера Фармасьютікалз, Інк. |
Збагачена дпк композиція омега-3 поліненасичених жирних кислот у формі вільної кислоти
|
CN109966279A
(zh)
|
2012-03-30 |
2019-07-05 |
微团生物制药有限公司 |
ω-3脂肪酸酯组合物
|
RU2645075C2
(ru)
|
2012-05-07 |
2018-02-15 |
Омтера Фармасьютикалс, Инк. |
Композиции статинов и омега-3 жирных кислот
|
US20140194512A1
(en)
|
2012-06-17 |
2014-07-10 |
Matinas Biopharma, Inc. |
Compositions comprising docosapentaenoic acid and methods of use
|
CA2916208A1
(en)
|
2012-06-17 |
2013-12-27 |
Matinas Biopharma, Inc. |
Omega-3 pentaenoic acid compositions and methods of use
|
GB201216385D0
(en)
*
|
2012-09-13 |
2012-10-31 |
Chrysalis Pharma Ag |
A pharmaceutical composition
|
WO2016069446A1
(en)
|
2014-10-28 |
2016-05-06 |
Omthera Pharmaceuticals Inc |
Methods for modulating plasma levels of lipoproteins
|
WO2016073335A1
(en)
|
2014-11-05 |
2016-05-12 |
Omthera Pharmaceuticals Inc. |
Methods of treatment
|
WO2016130417A1
(en)
|
2015-02-11 |
2016-08-18 |
Omthera Pharmaceuticals Inc |
Omega-3 fatty acid prodrug compounds and uses thereof
|
MA41611A
(fr)
|
2015-02-23 |
2018-01-02 |
Omthera Pharmaceuticals Inc |
Préparations en milli-capsules comprenant des acides gras polyinsaturés libres
|